Product Code: ETC6191087 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The sleep disorder treatment market in Australia includes pharmacological and non-pharmacological interventions for insomnia, sleep apnea, narcolepsy, and restless leg syndrome. Demand is rising due to growing mental health issues, aging demographics, and improved diagnostic services. The market is regulated by the Therapeutic Goods Administration (TGA), ensuring that treatments meet stringent safety and efficacy standards.
Australias sleep disorder treatment market is expanding as mental health awareness and diagnosis of sleep-related conditions improve. Pharmaceutical treatments remain significant, but there is a growing shift toward non-pharmacological options such as cognitive behavioral therapy for insomnia (CBT-I), wearable tech, and mobile-based therapy solutions. Public and private health initiatives are increasingly funding sleep disorder management programs.
This market faces complexities arising from the wide variety of sleep disorders, each requiring specialized diagnosis and tailored treatments, making it difficult to standardize care. There is also a shortage of trained sleep specialists and clinics across Australia, limiting patient access to effective therapies. Regulatory approval for new treatments, including drugs and devices, can be lengthy. Patient adherence to treatment regimens, especially for chronic conditions like insomnia or sleep apnea, remains a persistent challenge, affecting treatment outcomes.
This broad market presents vast investment opportunities encompassing pharmaceutical, device-based, and behavioral treatment options. Growing prevalence of disorders like insomnia, restless leg syndrome, and circadian rhythm disorders requires diversified product portfolios. Investment in digital therapeutics, cognitive behavioral therapy apps, and combination therapies backed by clinical research can meet evolving patient needs in Australia.
The broader sleep disorder treatment market is influenced by government health policies prioritizing mental and physical health. The TGA regulates pharmaceuticals and devices used in treatment, while the National Sleep Health Strategy promotes integrated care models. Funding for sleep clinics and research into sleep disorders reflects government commitment, facilitating market development.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Sleep Disorder Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Sleep Disorder Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Sleep Disorder Treatment Market - Industry Life Cycle |
3.4 Australia Sleep Disorder Treatment Market - Porter's Five Forces |
3.5 Australia Sleep Disorder Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Sleep Disorder Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Australia Sleep Disorder Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Australia Sleep Disorder Treatment Market Revenues & Volume Share, By Drugs Type, 2021 & 2031F |
3.9 Australia Sleep Disorder Treatment Market Revenues & Volume Share, By Population Type, 2021 & 2031F |
3.10 Australia Sleep Disorder Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 Australia Sleep Disorder Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Sleep Disorder Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about sleep disorders and their impact on overall health in Australia |
4.2.2 Growing prevalence of sleep disorders due to lifestyle changes and stress |
4.2.3 Technological advancements in sleep disorder diagnosis and treatment options |
4.3 Market Restraints |
4.3.1 Limited access to specialized sleep disorder treatment facilities in remote areas of Australia |
4.3.2 High cost associated with sleep disorder treatments and therapies |
4.3.3 Lack of trained healthcare professionals specializing in sleep disorders in Australia |
5 Australia Sleep Disorder Treatment Market Trends |
6 Australia Sleep Disorder Treatment Market, By Types |
6.1 Australia Sleep Disorder Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Sleep Disorder Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Sleep Disorder Treatment Market Revenues & Volume, By Insomnia, 2021- 2031F |
6.1.4 Australia Sleep Disorder Treatment Market Revenues & Volume, By Sleep Apnea, 2021- 2031F |
6.1.5 Australia Sleep Disorder Treatment Market Revenues & Volume, By Restless Legs Syndrome (RLS), 2021- 2031F |
6.1.6 Australia Sleep Disorder Treatment Market Revenues & Volume, By Narcolepsy, 2021- 2031F |
6.1.7 Australia Sleep Disorder Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Sleep Disorder Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Australia Sleep Disorder Treatment Market Revenues & Volume, By Pharmacological Therapy, 2021- 2031F |
6.2.3 Australia Sleep Disorder Treatment Market Revenues & Volume, By Mechanical Therapy, 2021- 2031F |
6.2.4 Australia Sleep Disorder Treatment Market Revenues & Volume, By Mandibular Advancement Devices, 2021- 2031F |
6.2.5 Australia Sleep Disorder Treatment Market Revenues & Volume, By Hypoglossal Nerve Stimulator, 2021- 2031F |
6.2.6 Australia Sleep Disorder Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.7 Australia Sleep Disorder Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Sleep Disorder Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Sleep Disorder Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Australia Sleep Disorder Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Australia Sleep Disorder Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Sleep Disorder Treatment Market, By Drugs Type |
6.4.1 Overview and Analysis |
6.4.2 Australia Sleep Disorder Treatment Market Revenues & Volume, By Generics, 2021- 2031F |
6.4.3 Australia Sleep Disorder Treatment Market Revenues & Volume, By Branded, 2021- 2031F |
6.5 Australia Sleep Disorder Treatment Market, By Population Type |
6.5.1 Overview and Analysis |
6.5.2 Australia Sleep Disorder Treatment Market Revenues & Volume, By Adults, 2021- 2031F |
6.5.3 Australia Sleep Disorder Treatment Market Revenues & Volume, By Children, 2021- 2031F |
6.6 Australia Sleep Disorder Treatment Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Australia Sleep Disorder Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Australia Sleep Disorder Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Australia Sleep Disorder Treatment Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.6.5 Australia Sleep Disorder Treatment Market Revenues & Volume, By Ambulatory Surgical Center, 2021- 2031F |
6.6.6 Australia Sleep Disorder Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Australia Sleep Disorder Treatment Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Australia Sleep Disorder Treatment Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.7.3 Australia Sleep Disorder Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.4 Australia Sleep Disorder Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.5 Australia Sleep Disorder Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.6 Australia Sleep Disorder Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Sleep Disorder Treatment Market Import-Export Trade Statistics |
7.1 Australia Sleep Disorder Treatment Market Export to Major Countries |
7.2 Australia Sleep Disorder Treatment Market Imports from Major Countries |
8 Australia Sleep Disorder Treatment Market Key Performance Indicators |
8.1 Average wait time for sleep disorder treatment appointments |
8.2 Patient satisfaction rates with sleep disorder treatment facilities and services |
8.3 Percentage of patients successfully managing their sleep disorders with treatment interventions |
8.4 Number of research studies and clinical trials related to sleep disorder treatments in Australia |
8.5 Adoption rate of innovative sleep disorder treatment technologies in healthcare institutions |
9 Australia Sleep Disorder Treatment Market - Opportunity Assessment |
9.1 Australia Sleep Disorder Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Sleep Disorder Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Australia Sleep Disorder Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Australia Sleep Disorder Treatment Market Opportunity Assessment, By Drugs Type, 2021 & 2031F |
9.5 Australia Sleep Disorder Treatment Market Opportunity Assessment, By Population Type, 2021 & 2031F |
9.6 Australia Sleep Disorder Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Australia Sleep Disorder Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Sleep Disorder Treatment Market - Competitive Landscape |
10.1 Australia Sleep Disorder Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Sleep Disorder Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |